Webinars

Speaker: Thomas Hartung, MD, PhD, Consulting VP of Scientific Affairs at AxoSim and Professor and Chair, Johns Hopkins University

Neurological impairments are usually irreversible because of limited regeneration in the central nervous system. The regenerative capacity of stem cells makes them an attractive candidate for transplantation therapies, with many stem cells showing promise in basic research and preclinical trials.

Learn about how advances in iPSC-derived organoid models recapitulate the “real” brain environment for CNS precision medicine.

Speaker: Anup Sharma, PhD, Lead Scientist at AxoSim

Learn about the use of Human Schwann Cells in preclinical peripheral neuropathy research. In this webinar, Dr. Sharma presents on our human peripheral neurotoxicity assay with Schwann Cells which recapitulates peripheral neuropathy in small molecules and antibody drug conjugates.

Speaker: Rakesh Dixit, PhD, DABT, President and CEO, Bionavigen

Peripheral Neuropathy is a common side effect of many Antibody Drug Conjugates. What are the pitfalls of using traditional preclinical testing models? Learn about the past, present, and future of ADCs and predictive assays testing peripheral neuropathy side effects.

Speakers: Helena Hogberg, PhD, Deputy Director of Center for Alternatives to Animal Testing at Johns Hopkins University Bloomberg School of Public Health and Lowry Curley, PhD, Co-Founder and CEO, AxoSim

NerveSim™ and BrainSim™ are two cutting-edge platforms that mimic the PNS and CNS. Learn about the latest research regarding NerveSim™’s ability to recapitulate peripheral neuropathy in four common chemotherapeutics and BrainSim™’s use in neurological effects of COVID-19.